Interestingly, our results demonstrated that BCs with Rab27B high expression displayed the enhanced expression of the mesenchymal markers vimentin and fibronectin, and decreased expression of the epithelial markers E-cadherin and β-catenin, suggesting an EMT process during Rab27B-regulating BC development. The gene discussed is RAB27B; the disease is breast cancer.